A phase-II study of neoadjuvant chemotherapy in T3-4N0-XM0 transitional cell carcinoma of the bladder: a preliminary analysis

Eur Urol. 1988:14 Suppl 1:24-6. doi: 10.1159/000473035.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Transitional Cell / drug therapy*
  • Cisplatin / administration & dosage
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Methotrexate / administration & dosage
  • Middle Aged
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Cisplatin
  • Methotrexate